Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 2.01
-2.9 %
$ 768 M
Market Cap
-14.36
P/E
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia.[ Read More ]
The intrinsic value of one CRON stock under the base case scenario is HIDDEN Compared to the current market price of 2.01 USD, Cronos Group Inc. is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart CRON
FINANCIALS
88.8 M
REVENUE
-81.4 M
OPERATING INCOME
-71.1 M
NET INCOME
-42.8 M
OPERATING CASH FLOW
-59.5 M
INVESTING CASH FLOW
-1.03 M
FINANCING CASH FLOW
46.6 M
REVENUE
7.32 M
OPERATING INCOME
7.32 M
NET INCOME
0
OPERATING CASH FLOW
0
INVESTING CASH FLOW
0
FINANCING CASH FLOW
Balance Sheet Decomposition
Cronos Group Inc.
| Current Assets | 933 M |
| Cash & Short-Term Investments | 862 M |
| Receivables | 35.7 M |
| Other Current Assets | 36.1 M |
| Non-Current Assets | 207 M |
| Long-Term Investments | 19.5 M |
| PP&E | 60.8 M |
| Other Non-Current Assets | 126 M |
| Current Liabilities | 41.4 M |
| Accounts Payable | 12.1 M |
| Short-Term Debt | 994 K |
| Other Current Liabilities | 28.3 M |
| Non-Current Liabilities | 2.55 M |
| Long-Term Debt | 1.56 M |
| Other Non-Current Liabilities | 990 K |
EFFICIENCY
Earnings Waterfall
Cronos Group Inc.
| Revenue | 88.8 M |
| Cost Of Revenue | 81.8 M |
| Gross Profit | 6.99 M |
| Operating Expenses | 96.7 M |
| Operating Income | -81.4 M |
| Other Expenses | -10.2 M |
| Net Income | -71.1 M |
RATIOS
7.87%
GROSS MARGIN
-91.60%
OPERATING MARGIN
-83.25%
NET MARGIN
-6.73%
ROE
-6.52%
ROA
-7.08%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Cronos Group Inc.
| Net Income | -71.1 M |
| Depreciation & Amortization | 8.26 M |
| Capital Expenditures | -3.42 M |
| Stock-Based Compensation | 8.77 M |
| Change in Working Capital | -27 M |
| Others | -3.66 M |
| Free Cash Flow | -45.4 M |
Wall Street Analysts Price Targets
Cronos Group Inc.
Wall Street analysts predict an average 1-year price target for CRON of $3.15 , with forecasts ranging from a low of $2.3 to a high of $4.5 .
CRON Lowest Price Target
Wall Street Target
2.3 USD
14.43%
CRON Average Price Target
Wall Street Target
3.15 USD
56.72%
CRON Highest Price Target
Wall Street Target
4.5 USD
123.88%
4. DIVIDEND ANALYSIS
0.00%
DIVIDEND YIELD
0 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Cronos Group Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
1 year ago
May 30, 2023
|
Bought 45.6 K USD
|
ADLER JASON MARC
Director |
+ 26250
|
1.7353 USD |
|
1 year ago
May 30, 2023
|
Bought 19.5 K USD
|
ADLER JASON MARC
Director |
+ 11250
|
1.7353 USD |
|
1 year ago
May 25, 2023
|
Bought 126 K USD
|
ADLER JASON MARC
Director |
+ 69999
|
1.7965 USD |
|
1 year ago
May 25, 2023
|
Bought 53.9 K USD
|
ADLER JASON MARC
Director |
+ 30001
|
1.7965 USD |
|
1 year ago
May 23, 2023
|
Bought 133 K USD
|
ADLER JASON MARC
Director |
+ 69999
|
1.9022 USD |
|
1 year ago
May 23, 2023
|
Bought 57.1 K USD
|
ADLER JASON MARC
Director |
+ 30001
|
1.9022 USD |
|
1 year ago
May 19, 2023
|
Bought 132 K USD
|
ADLER JASON MARC
Director |
+ 70000
|
1.8901 USD |
|
1 year ago
May 19, 2023
|
Bought 56.7 K USD
|
ADLER JASON MARC
Director |
+ 30000
|
1.8901 USD |
|
1 year ago
May 18, 2023
|
Bought 14.4 K USD
|
ADLER JASON MARC
Director |
+ 7994
|
1.7982 USD |
|
1 year ago
May 17, 2023
|
Bought 71 K USD
|
ADLER JASON MARC
Director |
+ 41505
|
1.7118 USD |
|
1 year ago
May 18, 2023
|
Bought 6.16 K USD
|
ADLER JASON MARC
Director |
+ 3426
|
1.7982 USD |
|
1 year ago
May 17, 2023
|
Bought 30.5 K USD
|
ADLER JASON MARC
Director |
+ 17795
|
1.7118 USD |
|
1 year ago
May 16, 2023
|
Bought 91.5 K USD
|
ADLER JASON MARC
Director |
+ 53269
|
1.7176 USD |
|
1 year ago
May 15, 2023
|
Bought 23.3 K USD
|
ADLER JASON MARC
Director |
+ 13300
|
1.7556 USD |
|
1 year ago
May 16, 2023
|
Bought 39.2 K USD
|
ADLER JASON MARC
Director |
+ 22831
|
1.7176 USD |
|
1 year ago
May 15, 2023
|
Bought 10 K USD
|
ADLER JASON MARC
Director |
+ 5700
|
1.7556 USD |
|
1 year ago
Dec 15, 2022
|
Bought 215 K USD
|
ADLER JASON MARC
Director |
+ 76711
|
2.8067 USD |
|
1 year ago
Dec 14, 2022
|
Bought 187 K USD
|
ADLER JASON MARC
Director |
+ 66219
|
2.8288 USD |
|
1 year ago
Dec 15, 2022
|
Bought 92.3 K USD
|
ADLER JASON MARC
Director |
+ 32877
|
2.8067 USD |
|
1 year ago
Dec 14, 2022
|
Bought 80.3 K USD
|
ADLER JASON MARC
Director |
+ 28381
|
2.8288 USD |
|
1 year ago
Dec 13, 2022
|
Bought 178 K USD
|
ADLER JASON MARC
Director |
+ 61706
|
2.8925 USD |
|
1 year ago
Dec 12, 2022
|
Bought 174 K USD
|
ADLER JASON MARC
Director |
+ 60199
|
2.8951 USD |
|
1 year ago
Dec 13, 2022
|
Bought 76.5 K USD
|
ADLER JASON MARC
Director |
+ 26446
|
2.8925 USD |
|
1 year ago
Dec 12, 2022
|
Bought 74.7 K USD
|
ADLER JASON MARC
Director |
+ 25801
|
2.8951 USD |
|
1 year ago
Dec 09, 2022
|
Bought 261 K USD
|
ADLER JASON MARC
Director |
+ 90299
|
2.8917 USD |
|
1 year ago
Dec 08, 2022
|
Bought 325 K USD
|
ADLER JASON MARC
Director |
+ 113679
|
2.8608 USD |
|
1 year ago
Dec 09, 2022
|
Bought 112 K USD
|
ADLER JASON MARC
Director |
+ 38701
|
2.8917 USD |
|
1 year ago
Dec 08, 2022
|
Bought 139 K USD
|
ADLER JASON MARC
Director |
+ 48721
|
2.8608 USD |
|
1 year ago
Dec 07, 2022
|
Bought 244 K USD
|
ADLER JASON MARC
Director |
+ 83299
|
2.9327 USD |
|
1 year ago
Dec 06, 2022
|
Bought 78.6 K USD
|
ADLER JASON MARC
Director |
+ 25900
|
3.0345 USD |
|
1 year ago
Dec 07, 2022
|
Bought 105 K USD
|
ADLER JASON MARC
Director |
+ 35701
|
2.9327 USD |
|
1 year ago
Dec 06, 2022
|
Bought 33.7 K USD
|
ADLER JASON MARC
Director |
+ 11100
|
3.0345 USD |
|
1 year ago
Nov 30, 2022
|
Bought 14.5 K USD
|
ADLER JASON MARC
Director |
+ 4760
|
3.0465 USD |
|
1 year ago
Nov 30, 2022
|
Bought 6.21 K USD
|
ADLER JASON MARC
Director |
+ 2040
|
3.0465 USD |
|
1 year ago
Nov 29, 2022
|
Bought 64.3 K USD
|
ADLER JASON MARC
Director |
+ 21140
|
3.0413 USD |
|
1 year ago
Nov 28, 2022
|
Bought 48.1 K USD
|
ADLER JASON MARC
Director |
+ 15890
|
3.0268 USD |
|
1 year ago
Nov 29, 2022
|
Bought 27.6 K USD
|
ADLER JASON MARC
Director |
+ 9060
|
3.0413 USD |
|
1 year ago
Nov 28, 2022
|
Bought 20.6 K USD
|
ADLER JASON MARC
Director |
+ 6810
|
3.0268 USD |
|
1 year ago
Nov 23, 2022
|
Bought 7.46 K USD
|
ADLER JASON MARC
Director |
+ 2450
|
3.0429 USD |
|
1 year ago
Nov 22, 2022
|
Bought 106 K USD
|
ADLER JASON MARC
Director |
+ 34860
|
3.0357 USD |
|
1 year ago
Nov 23, 2022
|
Bought 3.2 K USD
|
ADLER JASON MARC
Director |
+ 1050
|
3.0429 USD |
|
1 year ago
Nov 22, 2022
|
Bought 45.4 K USD
|
ADLER JASON MARC
Director |
+ 14940
|
3.0357 USD |
|
2 years ago
Nov 18, 2022
|
Bought 62.7 K USD
|
ADLER JASON MARC
Director |
+ 20580
|
3.0445 USD |
|
2 years ago
Nov 17, 2022
|
Bought 166 K USD
|
ADLER JASON MARC
Director |
+ 56699
|
2.935 USD |
|
2 years ago
Nov 18, 2022
|
Bought 26.9 K USD
|
ADLER JASON MARC
Director |
+ 8820
|
3.0445 USD |
|
2 years ago
Nov 17, 2022
|
Bought 71.3 K USD
|
ADLER JASON MARC
Director |
+ 24301
|
2.935 USD |
|
2 years ago
Nov 16, 2022
|
Bought 230 K USD
|
ADLER JASON MARC
Director |
+ 77601
|
2.9656 USD |
|
2 years ago
Nov 15, 2022
|
Bought 368 K USD
|
ADLER JASON MARC
Director |
+ 118998
|
3.0963 USD |
|
2 years ago
Nov 16, 2022
|
Bought 98.6 K USD
|
ADLER JASON MARC
Director |
+ 33259
|
2.9656 USD |
|
2 years ago
Nov 15, 2022
|
Bought 158 K USD
|
ADLER JASON MARC
Director |
+ 51002
|
3.0963 USD |
|
3 years ago
Mar 17, 2021
|
Sell 7.19 M USD
|
ADLER JASON MARC
Director |
- 714759
|
10.0657 USD |
|
3 years ago
Mar 15, 2021
|
Sell 4.82 M USD
|
ADLER JASON MARC
Director |
- 452810
|
10.6527 USD |
|
3 years ago
Mar 11, 2021
|
Sell 3.31 M USD
|
GORENSTEIN MICHAEL RYAN
Executive Chairman |
- 324411
|
10.1954 USD |
|
3 years ago
Mar 12, 2021
|
Sell 1.55 M USD
|
GORENSTEIN MICHAEL RYAN
Executive Chairman |
- 150000
|
10.3498 USD |
|
3 years ago
Mar 15, 2021
|
Sell 1.4 M USD
|
GORENSTEIN MICHAEL RYAN
Executive Chairman |
- 130000
|
10.7315 USD |
|
3 years ago
Mar 09, 2021
|
Sell 1.85 M USD
|
GORENSTEIN MICHAEL RYAN
Executive Chairman |
- 185000
|
9.9962 USD |
|
3 years ago
Mar 02, 2021
|
Sell 2.54 M USD
|
GORENSTEIN MICHAEL RYAN
Executive Chairman |
- 230000
|
11.0458 USD |
|
3 years ago
Mar 03, 2021
|
Sell 1.18 M USD
|
GORENSTEIN MICHAEL RYAN
Executive Chairman |
- 114015
|
10.3869 USD |
|
3 years ago
Mar 01, 2021
|
Sell 61.2 K USD
|
JACOBSON JEFFREY DAVID
See Remarks |
- 4500
|
13.6002 USD |
|
4 years ago
Nov 17, 2020
|
Sell 733 K USD
|
ADLER JASON MARC
Director |
- 100000
|
7.334 USD |
|
4 years ago
Nov 11, 2020
|
Sell 67.9 K USD
|
ADLER JASON MARC
Director |
- 9300
|
7.3 USD |
|
4 years ago
Nov 06, 2020
|
Sell 760 K USD
|
ADLER JASON MARC
Director |
- 100000
|
7.6018 USD |
|
4 years ago
Nov 09, 2020
|
Sell 5.95 M USD
|
ADLER JASON MARC
Director |
- 769339
|
7.7291 USD |
|
4 years ago
Nov 10, 2020
|
Sell 156 K USD
|
ADLER JASON MARC
Director |
- 21361
|
7.3005 USD |
|
4 years ago
Nov 06, 2020
|
Sell 8.46 M USD
|
GORENSTEIN MICHAEL RYAN
Executive Chairman |
- 1181499
|
7.1621 USD |
|
4 years ago
Nov 06, 2020
|
Sell 854 K USD
|
GORENSTEIN MICHAEL RYAN
Executive Chairman |
- 107851
|
7.9177 USD |
|
4 years ago
Aug 07, 2020
|
Bought 86.8 K USD
|
ABRAHAM TODD KEVIN
Chief Innovation Officer |
+ 15000
|
5.7837 USD |
7. News
Why Cronos Group Stock Popped 9% Today
Cronos stock just went up -- a lot. Maybe it's time to sell?
fool.com
- 4 days ago
Cronos Group Inc. (CRON) Q3 2024 Earnings Call Transcript
Cronos Group Inc. (NASDAQ:CRON ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Anna Shlimak - Chief Strategy Officer Mike Gorenstein - Chairman, President and CEO James Holm - CFO Conference Call Participants Matt Bottomley - Canaccord Genuity Bill Kirk - Roth Capital Partners Operator Good morning. My name is Brianna and I will be your conference operator today.
seekingalpha.com
- 4 days ago
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
nypost.com
- 1 week ago
Cannabis stocks tank as Florida votes against recreational marijuana
Shares in cannabis stocks such as Trulieve Cannabis Corp. (CSE:TRUL), Curaleaf Hldgs Inc. (CSE:CURA, OTCQX:CURLF) and Verano Holdings Corp (CSE:VRNO, OTCQX:VRNOF) tanked after Florida rejected legalization of recreational marijuana. A ballot measure, known as Amendment 3, which would have allowed adults to possess up to three ounces of marijuana, failed to obtain the required 60% of support from voters yesterday.
proactiveinvestors.com
- 1 week ago
Top Canadian Cannabis Stocks to Track as U.S. Legalization Heats Up
As the election approaches, Canadian cannabis stocks are capturing attention, especially with potential U.S. legalization developments on the horizon. The U.S. cannabis industry is booming, with projected growth reaching $41 billion by 2025. This massive market is appealing to Canadian companies seeking new revenue streams. Florida, in particular, is considering the legalization of recreational cannabis, which could unlock significant growth for Canadian cannabis companies with existing U.S. ties. If Florida joins the ranks of legal states, Canadian companies like Tilray, Canopy Growth, and Cronos Group could capitalize on this opportunity. These stocks are increasingly appealing to investors looking to benefit from potential changes in the U.S. market.
marijuanastocks.com
- 1 week ago
5 Stocks Backed by High Efficiency for Solid Gains Amid Volatility
Invest in stocks of AMRX, CRON, CSV, BFST and APH to tap their high-efficiency levels.
zacks.com
- 1 week ago
Cronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024
TORONTO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 third quarter earnings conference call on Tuesday, November 12, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.
globenewswire.com
- 2 weeks ago
Spinach® Is the Number One Cannabis Brand in Canada
TORONTO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, is proud to announce that its award-winning brand Spinach® has risen to the best-selling cannabis brand in the Canadian market.1 Spinach's market share outperformance represents Cronos' relentless commitment to quality, innovation, and bringing differentiated products to the competitive Canadian adult-use market.
globenewswire.com
- 1 month ago
3 Cannabis Stocks to Monitor as the Election Approaches
For most of the campaign cycle, those bullish on cannabis stocks viewed a Vice President Kamala Harris presidency as the most beneficial to the sector.
schaeffersresearch.com
- 1 month ago
These Canadian Marijuana Stocks Could Be The Winners You Need
With most marijuana stocks still showing volatile trading is now the time to buy? Well, it's not such an easy answer as some may find the volatile behavior of marijuana stocks to be in their favor. The cannabis sector has been showing a large amount of volatility for some time. What this means is the slightest factor can impact how the better part of the sector trades. Often leading to a downtrend for most marijuana stocks until such time there is a means to see a recovery.
marijuanastocks.com
- 1 month ago
3 Marijuana Stocks To Watch On September 11th
Over the last several days some marijuana stocks have begun to pick up in momentum. There have been several attempts to show good faith in the legalization efforts for cannabis markets across the USA. Recently Trump has shown his support for legal cannabis in Florida under the right conditions. From this news, more people began to speculate that Trump's support can mean big things for legal cannabis. In addition to fueling more profitable trading in the hopes of better reform measures.
marijuanastocks.com
- 2 months ago
3 Marijuana Stocks To Watch In The Stock Market Today
Many legal cannabis operators are working to keep pushing the boundaries of the industry. Innovation is key for any growing sector and cannabis is no different. Right now is a pivotal time for the cannabis industry as things are continuously changing. The climate of the sector and the success of companies can have a direct connection to how most marijuana stocks perform, especially during an election year where promises may come along from presidential candidates to better the industry.
marijuanastocks.com
- 2 months ago
8. Profile Summary
Cronos Group Inc. CRON
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 768 M
Dividend Yield
0.00%
Description
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Contact
111 Peter Street, Toronto, ON, M5V 2H1
https://www.thecronosgroup.com
IPO Date
Feb. 27, 2018
Employees
356
Officers
Mr. Jeffrey David Jacobson
Chief Growth Officer
Ms. Shannon Buggy
Senior Vice President & Global Head of People
Mr. Adam Wagner
Senior Vice President & Head of Cronos Israel
Ms. Anna Shlimak
Chief Strategy Officer
Mr. Arye Weigensberg
Senior Vice President and Head of Research & Development
Mr. James Holm
Chief Financial Officer
Mr. Michael Ryan Gorenstein J.D.
President, Chief Executive Officer & Chairman
Mr. Terry Gregory-Joseph Doucet
General Counsel & Corporate Secretary
Mr. James Andrew McGinness III
Vice President, Controller & Principal Accounting Officer
Mr. Shayne J. Laidlaw
Director of Investor Relations & Strategy